These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 37396707)

  • 21. SARS-CoV-2 infection and smoking: What is the association? A brief review.
    Gupta I; Sohail MU; Elzawawi KE; Amarah AH; Vranic S; Al-Asmakh M; Al Moustafa AE
    Comput Struct Biotechnol J; 2021; 19():1654-1660. PubMed ID: 33777332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories.
    Simmonds P
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly pathogenic coronaviruses and the kidney.
    Wang F; Suo XG; Wang C; Wang JN; He XY; Wang FC; Jin J; Wen JG; Ni WJ; Shen BX; Meng XM
    Biomed Pharmacother; 2022 Dec; 156():113807. PubMed ID: 36242850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronavirus Disease 2019 (COVID-19) and Nutritional Status: The Missing Link?
    Silverio R; Gonçalves DC; Andrade MF; Seelaender M
    Adv Nutr; 2021 Jun; 12(3):682-692. PubMed ID: 32975565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
    Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
    Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperglycemia in COVID-19 infection without diabetes mellitus: Association with inflammatory markers.
    Geetha HS; Singh G; Sekar A; Gogtay M; Singh Y; Abraham GM; Trivedi N
    World J Clin Cases; 2023 Feb; 11(6):1287-1298. PubMed ID: 36926123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
    Wu Z; Harrich D; Li Z; Hu D; Li D
    Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes.
    Kountouri A; Korakas E; Ikonomidis I; Raptis A; Tentolouris N; Dimitriadis G; Lambadiari V
    Antioxidants (Basel); 2021 May; 10(5):. PubMed ID: 34065123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urogenital System Damaging Manifestations of 3 Human Infected Coronaviruses.
    Wang Z; Wang D; Dai Y; Zhu S; Zeng H
    J Urol; 2021 Mar; 205(3):671-677. PubMed ID: 33026922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review.
    Elhabyan A; Elyaacoub S; Sanad E; Abukhadra A; Elhabyan A; Dinu V
    Virus Res; 2020 Nov; 289():198163. PubMed ID: 32918943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
    Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
    J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 and diabetes-Two giants colliding: From pathophysiology to management.
    Pelle MC; Zaffina I; Provenzano M; Moirano G; Arturi F
    Front Endocrinol (Lausanne); 2022; 13():974540. PubMed ID: 36060943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.
    Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P;
    Diabetes Care; 2020 Jul; 43(7):1427-1432. PubMed ID: 32409501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV.
    Goyal R; Gautam RK; Chopra H; Dubey AK; Singla RK; Rayan RA; Kamal MA
    EXCLI J; 2022; 21():1245-1272. PubMed ID: 36483910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
    Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
    Front Immunol; 2020; 11():1979. PubMed ID: 32973803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?
    Pugliese G; Vitale M; Resi V; Orsi E
    Acta Diabetol; 2020 Nov; 57(11):1275-1285. PubMed ID: 32865671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.